ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,760, issued on June 2, was assigned to RELEASE THERAPEUTICS SA (Geneva), LES HOPITAUX UNIVERSITAIRES DE GENEVE (Geneva) and UNIVERSITE DE GENEVE GENEVE (Geneva).

"Implantable capsule" was invented by Aurelien Lathuiliere (Geneva), Julien Grogg (Lausanne, Switzerland) and Nicolas Mach (Collonge-Bellerive, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Implantable capsule comprising a cell receiving portion (2) comprising a porous membrane (5) surrounding a cell receiving chamber (13) for receiving immortalized cells in a liquid media therein for the secretion of therapeutic agents. The capsule further comprises a cell support matrix (7) in...